Product group Injections / Infusions / Transfusions / Dialysis - probes
Reference 48122/25

Product group Surgical equipment/ Anaesthesia - anaesthesia and medical gas supply
Reference 48596/25

Product group Injections / Infusions / Transfusions / Dialysis - infusion technology
Reference 48593/25

Product group In-vitro diagnostics - equipment / products for clinical chemistry
Reference 48364/25

Product group Injections / Infusions / Transfusions / Dialysis - infusion technology
Reference 48945/25

Product group Optics / Precision engineering - endoscopes
Reference 47215/25

Product group Medical electronics / Electromedical devices - electrotherapy
Reference 46240/25

Product group Radiological technology - CT scanners
Reference 46209/25

Product group In-vitro diagnostics - immunological products
Reference 48779/25

Product group In-vitro diagnostics - equipment / products for clinical chemistry
Reference 38239/24

Product group Active implantable medical devices - biostimulators
Reference 48274/25

Product group Injections / Infusions / Transfusions / Dialysis - infusion technology
Reference 33610/25

Active substance: caspofungin The marketing authorisation holders of caspofungin containing medicines would like to inform that during treatment with caspofungin the use of polyacrylonitrile membranes during continuous renal replacement therapy should be avoided.

Product group Active implantable medical devices - artificial hearts
Reference 47997/25

Product group Orthopaedic / Rehabilitation technology - daily living aids
Reference 47553/25

Information on the change of marketing authorisation holder were added.

Product group In-vitro diagnostics - immunological products
Reference 46265/25

Product group Medical instruments for use in humans - bone surgery
Reference 46956/25

Product group Radiological technology - radiological equipment for vascular diagnostics
Reference 26421/24

Information on the change of marketing authorisation holder were added.